http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2449705-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 |
| filingDate | 2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f834e6947738214ce40b6b7ee65afd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_088073224cd859a5a9522b500fbbd334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00a7f40ab5a2872cd468ca50098cf9a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f91635eec447d660044ed59db1053d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c6bd42480d9fe1d4d2f5fedccfa876 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec5048de03e788f5f3c0177efacb2a99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_715691f58d65bfda2b7ef30317d1ddba |
| publicationDate | 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2449705-T3 |
| titleOfInvention | Heterocyclic carboxylic acid derivatives with a 2,5,7-substituted oxazolopyrimidine ring |
| abstract | Compound of formula I, in any of its stereoisomeric forms, or a mixture of stereoisomeric forms in any proportion, or its physiologically acceptable salt, or a physiologically acceptable solvate of any of these, ** Formula ** in which A is selected from NH, O and S; X is selected from alkanyl (C1-C6), alkenyl (C2-C6), alkyldiyl (C2-C6), cycloalkandiyl (C3-C7) and alkanoyloxy (C1-C6), all of which are optionally substituted with one or more substituents same or different selected from fluorine and hydroxy, in which the oxygen atom of the alkylethyloxy (C1-C6) group is attached to the group R2; Y represents a monocyclic or bicyclic heterocycle, saturated or partially unsaturated, of 4 members to 7 members which, in addition to the nitrogen atom of the ring shown in formula I, comprises 0, 1, 2 or 3 heteroatoms of the same or different ring selected from N, O and S, in which one or two of the additional ring nitrogen atoms may carry a hydrogen atom or a (C1-C4) alkyl substituent, and one of the ring sulfur atoms may carry one or two oxo groups, and wherein the heterocycle is optionally substituted at one or more ring carbon atoms with the same or different alkyl (C1-C4) substituents; R1 is selected from alkyl (C1-C6), alkenyl (C2-C6), alkynyl (C2-C6), cycloalkyl (C3-C7) -CtH2t- and Het-CtH2t-, in which t is selected from 0.1 , 2 and 3; R2 is selected from phenylene and a divalent moiety of a 5-membered or 6-membered monocyclic aromatic heterocycle, comprising 1, 2 or 3 same or different ring heteroatoms selected from N, O and S, in which one of the atoms of the ring nitrogen may carry a hydrogen atom or an R21 substituent, and in which the phenylene and the divalent moiety of an aromatic heterocycle are optionally substituted on one or more carbon atoms of the ring with the same or different R22 substituents; R3 is selected from alkyl (C1-C6), alkenyl (C2-C6), alkynyl (C2-C6), cycloalkyl (C3-C7) -CuH2u- and Het-CvH2v-, in which uyv are selected from 1 and 2 , or R3 represents a moiety of a monocyclic or bicyclic ring, saturated or unsaturated, from 3 members to 10 members, comprising 0, 1, 2, 3 or 4 heteroatoms of the same or different ring selected from N, O and S, in which one or two of the ring nitrogen atoms may carry a hydrogen atom or a (C1-C4) alkyl substituent, and one or two of the ring sulfur atoms may carry one or two oxo groups, and in the that the remainder of a ring is optionally substituted at one or more ring carbon atoms with the same or different R31 substituents, provided that R31 cannot represent (C1-C6) alkyl when A represents S; |
| priorityDate | 2010-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 432.